Keytruda (the Ron Walker) drug has side effects, and I think VLA has better stats. However, Keytruda still a good story for the market.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
